CureĀ® Unveils US Biotech Industry Benchmark Report 2024: Dark Days of 2023 are Over

79% respondents predict growth in 2024 and beyond Nearly half anticipate increasing R&D spend Neurology and metabolic diseases ranked top therapeutic areas of interest Interest in drug discovery overtakes digital health Most view women’s health as a priority, but agree funding is…